Carla Rovirosa Martí

Exploring FeLV-Gag-Based VLPs as a New Vaccine Platform-Analysis of Production and Immunogenicity.

Impact of hybrid immunity booster vaccination and Omicron breakthrough infection on SARS-CoV-2 VOCs cross-neutralization.

Alanine-based spacers promote an efficient antigen processing and presentation in neoantigen polypeptide vaccines.

Efficacy of SARS-CoV-2 vaccination in patients with monoclonal gammopathies: A cross sectional study.

Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes